BRPI0515376A - método para prevenir ou tratar diarréia em um mamìfero, composição útil na prevenção ou no tratamento de diarréia em um mamìfero, kit adequado para administrar um exopolissacarìdeo microbiano a um mamìfero, e, meio para comunicar informação - Google Patents

método para prevenir ou tratar diarréia em um mamìfero, composição útil na prevenção ou no tratamento de diarréia em um mamìfero, kit adequado para administrar um exopolissacarìdeo microbiano a um mamìfero, e, meio para comunicar informação

Info

Publication number
BRPI0515376A
BRPI0515376A BRPI0515376-0A BRPI0515376A BRPI0515376A BR PI0515376 A BRPI0515376 A BR PI0515376A BR PI0515376 A BRPI0515376 A BR PI0515376A BR PI0515376 A BRPI0515376 A BR PI0515376A
Authority
BR
Brazil
Prior art keywords
mammal
preventing
treating diarrhea
administering
communicating information
Prior art date
Application number
BRPI0515376-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Christina Khoo
Wai Cheuk
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BRPI0515376A publication Critical patent/BRPI0515376A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L25/00—Baseband systems
    • H04L25/02—Details ; arrangements for supplying electrical power along data transmission lines
    • H04L25/03—Shaping networks in transmitter or receiver, e.g. adaptive shaping networks
    • H04L25/03828—Arrangements for spectral shaping; Arrangements for providing signals with specified spectral properties
    • H04L25/03834—Arrangements for spectral shaping; Arrangements for providing signals with specified spectral properties using pulse shaping
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L27/00—Modulated-carrier systems
    • H04L27/18—Phase-modulated carrier systems, i.e. using phase-shift keying
    • H04L27/20—Modulator circuits; Transmitter circuits
    • H04L27/2003—Modulator circuits; Transmitter circuits for continuous phase modulation
    • H04L27/2007—Modulator circuits; Transmitter circuits for continuous phase modulation in which the phase change within each symbol period is constrained
    • H04L27/2017—Modulator circuits; Transmitter circuits for continuous phase modulation in which the phase change within each symbol period is constrained in which the phase changes are non-linear, e.g. generalized and Gaussian minimum shift keying, tamed frequency modulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Power Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0515376-0A 2004-09-16 2005-09-16 método para prevenir ou tratar diarréia em um mamìfero, composição útil na prevenção ou no tratamento de diarréia em um mamìfero, kit adequado para administrar um exopolissacarìdeo microbiano a um mamìfero, e, meio para comunicar informação BRPI0515376A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/942,397 US8685943B2 (en) 2003-03-12 2004-09-16 Methods for reducing diarrhea in a companion animal
PCT/US2005/033077 WO2006032005A2 (en) 2004-09-16 2005-09-16 Method and composition for preventing or treating diarrhea

Publications (1)

Publication Number Publication Date
BRPI0515376A true BRPI0515376A (pt) 2008-07-22

Family

ID=36060717

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515376-0A BRPI0515376A (pt) 2004-09-16 2005-09-16 método para prevenir ou tratar diarréia em um mamìfero, composição útil na prevenção ou no tratamento de diarréia em um mamìfero, kit adequado para administrar um exopolissacarìdeo microbiano a um mamìfero, e, meio para comunicar informação

Country Status (10)

Country Link
US (3) US8685943B2 (enExample)
EP (1) EP1796728A4 (enExample)
JP (1) JP2008513474A (enExample)
CN (2) CN101060861B (enExample)
AU (1) AU2005284784B2 (enExample)
BR (1) BRPI0515376A (enExample)
CA (1) CA2581020C (enExample)
RU (2) RU2563137C2 (enExample)
WO (1) WO2006032005A2 (enExample)
ZA (1) ZA200703100B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102271531A (zh) * 2009-01-06 2011-12-07 雀巢产品技术援助有限公司 果冻食物组合物中的块状物
JP5554350B2 (ja) * 2009-03-11 2014-07-23 ネステク ソシエテ アノニム 具材入り肉汁食品組成物
EP2588544A1 (fr) * 2010-07-02 2013-05-08 Ifremer (Institut Français De Recherche Pour L'Exploitation De La Mer) Exopolysaccharides pour la prévention et la lutte contre la formation de biofilms
EP2797426A1 (en) * 2011-12-29 2014-11-05 Hill's Pet Nutrition, Inc. Compositions and methods for modifying gastrointestinal flora
JP6452616B2 (ja) * 2012-12-04 2019-01-16 ネステク ソシエテ アノニム 擬似ローフ食品組成物
GB201519854D0 (en) * 2015-11-10 2015-12-23 Mars Inc Pet food
CN107296815A (zh) * 2017-06-29 2017-10-27 中国人民解放军第二军医大学 酵母多糖在制备防护急性放射性骨髓损伤药物中的应用
US11622974B2 (en) 2019-01-18 2023-04-11 C.P. Kelco U.S., Inc. Prebiotic composition and its use
RU2740380C1 (ru) * 2019-12-24 2021-01-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Биоинженерная конструкция на основе бактериального альгината и пробиотических бактерий и способ ее получения
TWI840668B (zh) * 2021-05-13 2024-05-01 陳昭誠 由β-1-4-葡聚醣形成之纖維於製備用於治療腸躁症之組成物之用途

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501484A (en) * 1975-10-24 1978-02-15 Tate & Lyle Ltd Icing mixture
US4410551A (en) * 1980-05-15 1983-10-18 Ralston Purina Company Gravy forming intermediate moisture pet food
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
US4647470A (en) * 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
US4822626A (en) * 1987-01-05 1989-04-18 Nabisco Brands, Inc. Coated canine biscuits
GB8710704D0 (en) 1987-05-06 1987-06-10 Mars G B Ltd Edible gels
EP0291228B1 (en) 1987-05-14 1991-08-28 Merck & Co. Inc. Gellan gum/starch blends
JPH01193388A (ja) 1987-10-09 1989-08-03 Agency Of Ind Science & Technol リオトロピック液晶セル
JP2769707B2 (ja) 1988-11-28 1998-06-25 大洋香料株式会社 透明水性ゲル状芳香剤組成物
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
DE69112260T2 (de) 1990-04-23 1996-04-11 Monsanto Co Gellan-Gummi-Fasern.
IT1248934B (it) 1990-06-01 1995-02-11 Fidia Spa Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
US5079024A (en) * 1990-09-25 1992-01-07 Kraft General Foods, Inc. Method of manufacture of a non-fat cream cheese product
US5158800A (en) * 1991-10-08 1992-10-27 Merck & Co., Inc. Non-sticky, fat-containing confection
JPH0690707A (ja) * 1992-01-06 1994-04-05 Asahi Chem Ind Co Ltd 緩下作用の改善された食物繊維組成物
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5419283A (en) * 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5372829A (en) * 1993-01-15 1994-12-13 Merck & Co., Inc. Process for preparing low-fat fried food
CA2125914A1 (en) 1993-06-25 1994-12-26 Pharmacia Corporation Oil-coated microparticulated gellan gum
US5339771A (en) * 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
US5571545A (en) * 1994-02-22 1996-11-05 Fuji Oil Company, Limited Hamburger type food material and process of making it
US5616569A (en) * 1994-03-28 1997-04-01 The Iams Company Pet food product containing fermentable fibers and process for treating gastrointestinal disorders
US5534286A (en) 1994-06-01 1996-07-09 Monsanto Company No-fat gellan gum spread
US5456937A (en) * 1994-06-24 1995-10-10 Chalupa; William F. Gellan gum flavor beads
US5596084A (en) * 1994-10-05 1997-01-21 Monsanto Company Alginate gels
JPH08157377A (ja) * 1994-12-02 1996-06-18 Nippon Oil Co Ltd 家畜等の下痢予防・治療剤
JP3836893B2 (ja) * 1995-01-24 2006-10-25 アボットジャパン株式会社 ポリカルボフィルカルシウム含有製剤
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
JPH09172980A (ja) * 1995-12-28 1997-07-08 Ajinomoto Co Inc 新規リン酸アミノ酸複合塩及び水溶性高分子を含有する反すう動物用飼料添加組成物
JP3955112B2 (ja) 1996-01-10 2007-08-08 エステー化学株式会社 ゲル状脱臭剤
JPH09194393A (ja) * 1996-01-22 1997-07-29 Meiji Milk Prod Co Ltd 免疫寛容を誘導する方法、免疫寛容誘導食品キットおよび免疫寛容誘導剤キット
JPH09201170A (ja) 1996-01-24 1997-08-05 Dainippon Pharmaceut Co Ltd ジェランガム含有α化澱粉
JPH09275973A (ja) 1996-04-12 1997-10-28 Suzuki Motor Corp 微生物用培地
GB2314840B (en) 1996-06-28 2000-09-06 Johnson & Johnson Medical Oxidized oligosaccharides and pharmaceutical compositions
JPH1067625A (ja) 1996-08-22 1998-03-10 Lion Corp 口腔用組成物
JPH10179050A (ja) 1996-12-27 1998-07-07 Sanei Gen F F I Inc ネイティブジェランガムを含有する食品
US6458404B1 (en) * 1996-08-27 2002-10-01 San-Ei Gen F.F.I., Inc. Dehydrated gel composition from hydrated isolated acetylated gellan gum
US5869118A (en) * 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
US5895804A (en) * 1997-10-27 1999-04-20 National Starch And Chemical Investment Holding Corporation Thermosetting polysaccharides
JP3874560B2 (ja) 1998-01-09 2007-01-31 旭化成ケミカルズ株式会社 微細セルロース含有複合物
TW408153B (en) 1998-01-09 2000-10-11 Asahi Chemical Ind Cellulose-containing composite, process for its preparation and use thereof
JP2002517568A (ja) 1998-06-10 2002-06-18 モンサント・ピーエルシー 改質ゲランガム組成物、その調製工程およびその用途
JP3633942B2 (ja) 1998-09-09 2005-03-30 キユーピー株式会社 嘔吐予防食品
US6242035B1 (en) 1998-11-23 2001-06-05 Cp Kelco U.S., Inc. Reduced molecular weight native gellan gum
NL1013175C2 (nl) 1999-09-29 2001-03-30 Nutricia Nv Voedingssamenstellingen die niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US6280779B1 (en) * 1999-12-28 2001-08-28 Colgate-Palmolive Company Pet food for maintaining normal bowel health
US6410079B2 (en) * 1999-12-28 2002-06-25 Hill's Pet Nutrition, Inc. High meat pet food compositions
US6426195B1 (en) * 2000-03-28 2002-07-30 Biogenex Lab Method for silver staining a pathologic sample
JP2001269125A (ja) 2000-03-29 2001-10-02 Nihon Nosan Kogyo Kk 豚用飼料
KR100437497B1 (ko) * 2001-03-07 2004-06-25 주식회사 프로바이오닉 로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
EP1250851A1 (en) * 2001-04-18 2002-10-23 Societe Des Produits Nestle S.A. Pet food composition containing semi-refined gelling agent
NZ515869A (en) 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
JP2003210075A (ja) * 2002-01-21 2003-07-29 Nippon Flour Mills Co Ltd 釣用疑似餌、その製造方法及び釣用疑似餌の製造用キット
GB0203431D0 (en) 2002-02-13 2002-04-03 Mars Inc Gel
JP2003259817A (ja) 2002-03-08 2003-09-16 Takeo Co Ltd ペット用冷菓組成物、それを用いたペット用冷菓およびペット用冷菓の製造方法
CN1395938A (zh) * 2002-09-03 2003-02-12 林斌 一种含低聚果糖的兽用口服液制剂
US7455869B2 (en) * 2002-12-19 2008-11-25 San-Ei Gen F.F.I., Inc. Composition for preparing artificial fruit flesh and food product containing the same
US20040168951A1 (en) 2003-02-27 2004-09-02 Mackie Robert W. Method and system for self administration of medications
US20040180079A1 (en) 2003-03-12 2004-09-16 Colgate-Palmolive Company Method and composition
US20050004071A1 (en) * 2003-04-21 2005-01-06 Comper Wayne D. Charged polysaccharides resistant to lysosomal degradation during kidney filtration and renal passage and their use to treat or prevent infection by coronaviruses
CA2530843A1 (en) 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use

Also Published As

Publication number Publication date
US8685943B2 (en) 2014-04-01
CN101060861A (zh) 2007-10-24
CN101060861B (zh) 2016-06-01
EP1796728A4 (en) 2008-07-23
US20080160164A1 (en) 2008-07-03
JP2008513474A (ja) 2008-05-01
RU2563137C2 (ru) 2015-09-20
CA2581020A1 (en) 2006-03-23
AU2005284784A1 (en) 2006-03-23
WO2006032005A2 (en) 2006-03-23
ZA200703100B (en) 2015-09-30
AU2005284784B2 (en) 2010-12-16
RU2007114054A (ru) 2008-10-27
CN105878267A (zh) 2016-08-24
RU2010135601A (ru) 2012-02-27
US20050042260A1 (en) 2005-02-24
US8563029B2 (en) 2013-10-22
US20140171386A1 (en) 2014-06-19
EP1796728A2 (en) 2007-06-20
WO2006032005A3 (en) 2006-10-19
US9028861B2 (en) 2015-05-12
CA2581020C (en) 2016-06-14

Similar Documents

Publication Publication Date Title
PT1280541E (pt) Utilizacao de estirpes acetogenicas hidrogenotroficas para a prevencao ou o tratamento de disturbios digestivos
BR0317110A (pt) Tratamento de doenças com combinações de agonistas do receptor nicotìnico da acetilcolina alfa 7 e outros compostos
BRPI0516437A (pt) utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
BRPI1006602A2 (pt) composto, método para modular um receptor de histamina em um indivíduo, composição farmacêutica, kit e método para tratar um distúrbio cognitivo ou um distúrbio induzido por pelo menos um sintoma associado com a alteração da cognição
BRPI0516727A (pt) métodos para tratar um linfoma positivo em cd30 , para inibir o crescimento de uma célula que expressa cd30, e para tratar ou prevenir uma doença
BR122017018225A8 (pt) Composição fungicida, seus usos, agente fungicida, método para controlar fungos nocivos fitopatogênicos, e semente resistente a fungos nocivos fitopatogênicos
BRPI0508410A8 (pt) composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
BRPI0515376A (pt) método para prevenir ou tratar diarréia em um mamìfero, composição útil na prevenção ou no tratamento de diarréia em um mamìfero, kit adequado para administrar um exopolissacarìdeo microbiano a um mamìfero, e, meio para comunicar informação
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
BRPI0921999B8 (pt) uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
BRPI0815850A2 (pt) "método para tratar, retardar a progressão, prevenir ou atrasar o desenvolvimento de esquizofrenia em um individuo, composiçã farmaceuticamente aceitável, kit e método para reforçar uma resposta de um individuo a um antipsicótico"
SG155054A1 (en) Human anti- neutralizing antibodies as selective pathway inhibitors
BRPI0414277A (pt) métodos e composições para o tratamento de dor e outras condições mediadas adrenérgicas alfa 2
BR0314690A (pt) Goma de mascar revestida
BRPI0518838A2 (pt) composiÇÕes tendo uma alta eficÁcia antiviral e antibactericida
BRPI0410348A (pt) compostos e usos dos mesmos na modulação de amilóide-beta
BRPI0813655A2 (pt) Composição farmacêutica, anticorpo específico para o componente de amilóide p sérico, composto que esgota componente de amilóide p sérico da circulação, uso de um composto, métodos para tratar ou prevenir um indivíduo que sofre de amiloidose, e para identificar um agente, e, kit para uso no tratamento de amiloidose
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
EP2513343A4 (en) METHOD AND COMPOSITIONS FOR TREATING SKIN INFLAMMATION
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
BRPI0507645A (pt) anticorpo, método de detectar um distúrbio ósseo metabólico, kit para detectar um distúrbio ósseo metabólico, composição farmacêutica para o tratamento de um distúrbio ósseo metabólico, e, método de triar uma substáncia efetiva para tratar e/ou prevenir um distúrbio ósseo metabólico
AU2021269176A8 (en) Single domain antibodies binding to SARS-CoV-2 spike protein
BR0110208A (pt) Composições e terapias para distúrbios associados com hiperlipidemia
UA94922C2 (ru) Способ регулирования специфичности сигнализации тканевого фактора у млекопитающего, которое нуждается в этом, способ идентификации агента, который специфически ингибирует сигнализацию тканевого фактора

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: HILL'S PET NUTRITION, INC. (US)

Free format text: TRANSFERIDO DE: COLGATE-PALMOLIVE COMPANY

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 47/00; A23K 1/17; A23K 1/165.

Ipc: A61K 31/715 (2006.01), A23K 20/163 (2016.01), A23K

Ipc: A61K 31/715 (2006.01), A23K 20/163 (2016.01), A23K

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2479 DE 10-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.